{
  "ptid_time": "057_S_0839_2006-09-20",
  "img_path": "/data/qiuhui/data/adni/images/057_S_0839/2006-09-20/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 28,087 mm³, 0.1% above the reference mean. With a Z-score of 0.00 (50.1th percentile), this represents normal volume ; hippocampal volume measures 5,561 mm³, 21.8% below the reference mean. With a Z-score of -2.00 (2.3th percentile), this represents significant atrophy; whole brain volume measures 795,508 mm³, 18.4% below the reference mean. With a Z-score of -2.31 (1.0th percentile), this represents significant atrophy; entorhinal cortex volume measures 2,634 mm³, 28.3% below the reference mean. With a Z-score of -1.74 (4.1th percentile), this represents moderate atrophy; fusiform gyrus volume measures 13,653 mm³, 19.7% below the reference mean. With a Z-score of -1.80 (3.6th percentile), this represents moderate atrophy; middle temporal gyrus volume measures 13,939 mm³, 27.3% below the reference mean. With a Z-score of -2.37 (0.9th percentile), this represents significant atrophy. ",
  "text_data": "Age is 79.4 years. Gender is Female. Education: 9 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Major Surgical Procedures. MMSE: 26.0. Logical Memory: 4.0. APOEε4 alleles: 0.0. Biomarker levels: Amyloid beta: 730.10 pg/mL (normal ); Total tau: 443.40 pg/mL (significant elevated); Phosphorylated tau: 44.42 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the hippocampus, whole brain, and middle temporal gyrus, along with moderate atrophy in the entorhinal cortex and fusiform gyrus—all regions heavily implicated in Alzheimer's disease (AD). The CSF biomarkers (normal Aβ but elevated T-tau and P-tau) suggest neurodegeneration consistent with AD pathology, despite the absence of APOE4. The MMSE of 26 is borderline but may reflect early cognitive impairment given the structural and biomarker findings.  \n\n**Diagnosis:** **Dementia (likely Alzheimer’s disease)**  \n**Confidence:** **High**  \n\n*(Key supporting evidence: Hippocampal/MTG atrophy + AD-typical CSF profile [Aβ-normal but tau elevation suggests non-amyloid tauopathy or late-stage amyloid clearance]. MMSE is near the MCI/dementia threshold but structural damage is severe.)*",
  "timestamp": "2025-07-26T08:05:27.071457"
}